ResMed result is no dream for investors say analysts

MELBOURNE: ResMed shares have fallen by as much as 3.3 per cent throughout ... read more

Ownership Matters adds up Mesoblast cash outflows

MELBOURNE: Get the marshmallows ready, the bonfire’s set to hit $1 billion at ... read more

Wesfarmers seeks more info from API on financial position

PERTH: Wesfarmers is believed to be lobbying Priceline owner Australian Pharmaceutical Industries for ... read more

Healius could be potential takeover target says expert

MELBOURNE: The Healius Ltd (ASX: HLS) share price has performed swimmingly in 2021. ... read more